X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New study finds hospitals prescribe more medicines, and more expensive medicines, after joining 340B program

By Nicole Longo  |    December 18, 2018
Data and analyses continue to show the 340B program influences prescribing trends at 340B hospitals – ultimately costing patients and our health care system more money. The Government...   Read More

Ask About Adherence: Poor medication adherence leads to negative health outcomes and increased health care costs

By Guest Contributor  |    December 18, 2018
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we are pleased to share a blog post from Xue Han.   Read More

New research shows increasing medication-assisted treatment rates could prevent 6.1 million overdoses and save over 800,000 lives

By Priscilla VanderVeer  |    December 17, 2018
New research released this week highlights the barriers that patients face in accessing medication-assisted treatment (MAT) for opioid use disorder (OUD) and the personal, health and societal...   Read More

Six key facts about the market for insulins

By Holly Campbell  |    December 17, 2018
The insulin market is commonly mischaracterized as lacking competition. In fact, robust competition among biopharmaceutical companies that produce insulin results in increasing levels of discounts...   Read More

New report shows nearly 300 cell and gene therapies in development

By Andrew Powaleny  |    December 6, 2018
Fifty years ago, the idea of altering a gene to treat or even cure a disease was considered science fiction. Today, cell and gene therapy are transforming treatment options for some patients and...   Read More

World AIDS Day 2018: Hope for the future

By Andrew Powaleny  |    December 1, 2018
Each year, I write to commemorate World AIDS Day which is now in its 30th year spotlighting patients living with HIV and those we’ve sadly lost to AIDS-related illnesses.   Read More

Groups sound the alarm on administration’s new Part B proposal

By Nicole Longo  |    November 14, 2018
Last month, the Administration announced a dangerous new proposal, the International Pricing Index Model, that would upend the delivery of Medicare Part B medicines. As PhRMA President and CEO...   Read More

4 things you need to know about the administration’s latest Part B proposal

By Nicole Longo  |    November 5, 2018
The Department of Health and Human Services (HHS) recently released an Advance Notice of Proposed Rulemaking regarding Medicare Part B that puts patient access to medicines and Part B at risk....   Read More

PhRMA submission to the 2019 National Trade Estimate Report urges action to protect U.S. biopharmaceutical innovation

By Douglas Petersen  |    November 2, 2018
International trade is critical to delivering life-saving and life-enhancing medicines in the global economy, which is why PhRMA addresses several discriminatory foreign government practices in...   Read More

PhRMA CEO discusses industry’s new approach to DTC television advertising

By Holly Campbell  |    October 17, 2018
PhRMA president and CEO Stephen J. Ubl joined CBS This Morning and MSNBC Live with Ali Velshi to discuss PhRMA member companies’ commitment to providing patients with the information they need to...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates